Serum GFAP and NfL augment a metabolomics-driven strategy for long-term prediction of multiple sclerosis progression
血清GFAP和NfL可增强代谢组学驱动的策略,用于长期预测多发性硬化症的进展。
期刊:
影响因子:
doi:10.1038/s43856-026-01453-5
Kacerova, Tereza; Willemse, Eline; Oechtering, Johanna; Radford-Smith, Daniel E; Xiong, Wenzheng; Sealey, Megan; Saldana, Luisa; Maleska Maceski, Aleksandra; Yeo, Tianrong; DeLuca, Gabriele; Palace, Jacqueline; Leppert, David; Kuhle, Jens; Anthony, Daniel C; Probert, Fay